The prevalence of acute cutaneous drug reactions in a Scandinavian University Hospital

Acta Dermato-Venereologica

Volumn 86, Issue 6, 2006, Pages 518-522

  Borch, Jakob E ^a   Andersen, Klaus E ^a   Bindslev Jensen, Carsten ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Drug allergy; Drug eruption; Pharmaco epidemiology; Pharmaco vigilance

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TESTIS BARRIER; CHILD; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; ECZEMA; FEMALE; HUMAN; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SCANDINAVIA; SKIN TEST; UNIVERSITY HOSPITAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; DRUG HYPERSENSITIVITY; ECZEMA; EXANTHEMA; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEASONS;

EID: 33845628170     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0143     Document Type: Article

References (21)

1. Macy E. Elective penicillin skin testing and amoxicillin challenge: effect on outpatient antibiotic use, cost, and clinical outcomes. J Allergy Clin Immunol 1998; 102: 281-285.
2. Solensky R, Earl HS, Gruchalla RS. Clinical approach to penicillin-allergic patients: a survey. Ann Allergy Asthma Immunol 2000; 84: 329-333.
3. Forrest DM, Schellenberg RR, Thien VV, King S, Anis AH, Dodek PM. Introduction of a practice guideline for penicillin skin testing improves the appropriateness of antibiotic therapy. Clin Infect Dis 2001; 32: 1685-1690.
4. Irawati L. Influence of penicillin allergy on antibiotic prescribing patterns and costs. Thesis. Curtin University of Technology, School of Pharmacy, Western Australia, 2003.
5. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358-3363.
6. Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997; 52: 388-393.
7. Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, Descamps V. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-1022.
8. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-1853.
9. Davies DM. Davies's textbook of adverse drug reactions, 5th edn. London: Chapman & Hall Medical, 1998.
10. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, Royer RJ. Adverse drug reaction monitoring: doing it the French way. Lancet 1985; 2: 1056-1058.
11. Skov PS, Mosbech H, Norn S, Weeke B. Sensitive glass microfibre-based histamine analysis for allergy testing in washed blood cells. Results compared with conventional leukocyte histamine release assay. Allergy 1985; 40: 213-218.
12. Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321-328.
13. Wahlberg JE, Lindberg M. Patch Testing. In: Frosch PJ, Menne T, Lepoittevin J-P, eds. Textbook of contact dermatitis, 4th edn. Berlin: Springer Verlag, 2006: 365-390.
14. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-863.
15. Litt JZ. Drug eruption reference manual, 10th edn. London: Taylor & Francis, 2004.
16. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2: 349-351.
17. Haddi E, Charpin D, Tafforeau M, Kulling G, Lanteaume A, Kleisbauer JP, Vervloet D. Atopy and systemic reactions to drugs. Allergy 1990; 45: 236-239.
18. Apaydin R, Bilen N, Dokmeci S, Bayramgurler D, Yildirim G. Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital. J Eur Acad Dermatol Venereol 2000; 14: 518-520.
19. Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49-58.
20. Stubb S, Heikkila H, Kauppinen K. Cutaneous reactions to drugs: a series of in-patients during a five-year period. Acta Derm Venereol 1994; 74: 289-291.
21. Lammintausta K, Kortekangas-Savolainen O. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol 2005; 85: 491-496.